In this Flash Talk, Rebecca Paul, Head of Medicinal Chemistry at Isomorphic Labs, explains how the company applies advanced AI models to develop and refine small molecule therapeutics. She discusses using breakthrough AI technology to support rational drug design and accelerate the discovery of new medicines.